ID   Hs 888.T
AC   CVCL_0979
SY   Hs-888-T; Hs888T; HS888T
DR   CLO; CLO_0004186
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7622
DR   BioSample; SAMN10988554
DR   cancercelllines; CVCL_0979
DR   Cell_Model_Passport; SIDM01746
DR   DepMap; ACH-000154
DR   GEO; GSM887126
DR   GEO; GSM888197
DR   IARC_TP53; 30071
DR   LiGeA; CCLE_713
DR   PharmacoDB; Hs888_T_606_2019
DR   Progenetix; CVCL_0979
DR   Wikidata; Q54896167
RX   DOI=10.1101/166199;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a osteosarcoma cell line but using a variety of omics methods was shown to be a a fibroblastic cell line (DOI=10.1101/166199; DepMap).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Genome ancestry: African=2.45%; Native American=0.69%; East Asian, North=0.26%; East Asian, South=1.64%; South Asian=7.7%; European, North=29.88%; European, South=57.38% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 8,12
ST   D5S818: 13
ST   D7S820: 7,11
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0977 ! Hs 888.Lu
OI   CVCL_0978 ! Hs 888.Sk
OI   CVCL_0987 ! Hs 894(A).T
OI   CVCL_0988 ! Hs 894(B).T
OI   CVCL_0989 ! Hs 894(C).T
OI   CVCL_0990 ! Hs 894(D).T
OI   CVCL_0991 ! Hs 894(E).Lu
OI   CVCL_0996 ! Hs 899(A).T
OI   CVCL_0997 ! Hs 899(B).T
OI   CVCL_0998 ! Hs 899(C).T
OI   CVCL_0999 ! Hs 899(D).T
SX   Male
AG   20Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 23
//
RX   DOI=10.1101/166199;
RA   de Weck A., Bitter H., Kauffmann A.;
RT   "Fibroblasts cell lines misclassified as cancer cell lines.";
RL   bioRxiv 2017:166199-166199(2017).
//
RX   PubMed=22460905; DOI=10.1038/nature11003;
RA   Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A.,
RA   Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A.,
RA   Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J.,
RA   Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E.,
RA   Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J.,
RA   Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C.,
RA   Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C.,
RA   Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P.,
RA   Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L.,
RA   Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R.,
RA   Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.;
RT   "The Cancer Cell Line Encyclopedia enables predictive modelling of
RT   anticancer drug sensitivity.";
RL   Nature 483:603-607(2012).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//